ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 212509 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 212509; 2) Community: the network communities that were significantly associated with the response to NSC 212509; 3) Molecule: the relationships between components within communities and NSC 212509; 4) MDR: the compounds that were significantly associated with the NSC 212509.

NSC Compound Enrichment Correlation
NSC 736200 6-(3-Bromopropyl)-5,6-dihydro3-nitro-5,11-dioxo-9-thiomethyl -11H-indeno[1,2-c]isoquinoline 0.0467178916101838 0.12378217
NSC 743862 Null 0.0467178916101838 0.30692499
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0467178916101838 0.42296994
NSC 747174 Null 0.0467178916101838 0.36834983
NSC 756169 GSK317314A 0.0467178916101838 0.14947944
NSC 758664 Sirolimus [USAN] 0.0467178916101838 -0.21433274
NSC 758682 ARTENIMOL 0.0467178916101838 0.39765978
NSC 761980 Null 0.0467178916101838 0.37576881
NSC 89822 Null 0.0467178916101838 0.28915125
NSC 100071 component of Halotex 0.0467178916101842 0.50644187
Total:145  Current:133    [First] [Prev] [Next] [Last]